Acute myocardial infarction during pregnancy.

Area of Science:

• Cardiology
• Obstetrics & Gynecology
• Maternal-Fetal Medicine

Background:

• Myocardial infarction during pregnancy contributes significantly to maternal morbidity and mortality.
• Increasing prevalence of obesity, diabetes, chronic hypertension, and advanced maternal age are expected to further elevate myocardial infarction rates in pregnancy.
• Maternal fetal medicine specialists require updated knowledge on managing acute coronary syndromes in pregnant individuals.

Purpose of the Study:

• To outline the fundamental initial medical management strategies for pregnant patients experiencing an acute coronary syndrome.
• To emphasize the critical role of early medical interventions in improving maternal and fetal outcomes.

Main Methods:

• Review of current guidelines and literature on acute coronary syndrome management in pregnancy.
• Focus on initial pharmacological treatments, including antiplatelet and antithrombotic agents.
• Discussion of the integration of percutaneous coronary intervention in managing myocardial infarction during pregnancy.

Main Results:

• Percutaneous coronary intervention has significantly enhanced outcomes for myocardial infarction in pregnancy.
• Early administration of antiplatelet and antithrombotic therapies is crucial for effective management.
• A multidisciplinary approach involving cardiologists and maternal fetal medicine specialists is vital.

Conclusions:

• Prompt and appropriate medical management, including timely percutaneous coronary intervention, can mitigate maternal morbidity and mortality associated with myocardial infarction in pregnancy.
• Familiarity with acute coronary syndrome protocols is essential for maternal fetal medicine specialists.
• The article provides a foundational guide for the initial medical management of these complex cases.